Artwork

Inhoud geleverd door The Johns Hopkins Bloomberg School of Public Health. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door The Johns Hopkins Bloomberg School of Public Health of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

812 - The Potentially “Game-changing” RSV Products Available This Season

13:40
 
Delen
 

Manage episode 446471204 series 2635898
Inhoud geleverd door The Johns Hopkins Bloomberg School of Public Health. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door The Johns Hopkins Bloomberg School of Public Health of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
About this episode:

Respiratory syncytial virus can be particularly dangerous for older adults and infants and this year, for the first time, there are three approved and readily available products to help prevent severe disease: A vaccine for pregnant women and people over age 65, and an antibody treatment for infants born during RSV season. In this episode: all about these products and they promise they show for dramatically reducing the number of hospitalizations and deaths from RSV this year.

Guests:

Dr. Georgina Peacock is the director of the Immunization Services Division in the National Center on Immunization and Respiratory Diseases at the CDC.

Host:

Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland’s Health Department.

Show links and related content: Contact us:

Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.

Follow us:
  continue reading

782 afleveringen

Artwork
iconDelen
 
Manage episode 446471204 series 2635898
Inhoud geleverd door The Johns Hopkins Bloomberg School of Public Health. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door The Johns Hopkins Bloomberg School of Public Health of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
About this episode:

Respiratory syncytial virus can be particularly dangerous for older adults and infants and this year, for the first time, there are three approved and readily available products to help prevent severe disease: A vaccine for pregnant women and people over age 65, and an antibody treatment for infants born during RSV season. In this episode: all about these products and they promise they show for dramatically reducing the number of hospitalizations and deaths from RSV this year.

Guests:

Dr. Georgina Peacock is the director of the Immunization Services Division in the National Center on Immunization and Respiratory Diseases at the CDC.

Host:

Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland’s Health Department.

Show links and related content: Contact us:

Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.

Follow us:
  continue reading

782 afleveringen

Alle afleveringen

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding